Works by Glatting, Gerhard


Results: 106
    1
    2
    3

    F Oximetry with semifluorinated alkanes.

    Published in:
    Artificial Cells, Nanomedicine & Biotechnology, 2016, v. 44, n. 8, p. 1861, doi. 10.3109/21691401.2015.1111228
    By:
    • Kegel, Stefan;
    • Chacon-Caldera, Jorge;
    • Tsagogiorgas, Charalambos;
    • Theisinger, Bastian;
    • Glatting, Gerhard;
    • Schad, Lothar R.
    Publication type:
    Article
    4

    Quantitative analysis of regional distribution of tau pathology with <sup>11</sup>C-PBB3-PET in a clinical setting.

    Published in:
    PLoS ONE, 2022, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0266906
    By:
    • Yousefzadeh-Nowshahr, Elham;
    • Winter, Gordon;
    • Bohn, Peter;
    • Kneer, Katharina;
    • von Arnim, Christine A. F.;
    • Otto, Markus;
    • Solbach, Christoph;
    • Anderl-Straub, Sarah;
    • Polivka, Dörte;
    • Fissler, Patrick;
    • Strobel, Joachim;
    • Kletting, Peter;
    • Riepe, Matthias W.;
    • Higuchi, Makoto;
    • Glatting, Gerhard;
    • Ludolph, Albert;
    • Beer, Ambros J.
    Publication type:
    Article
    5
    6

    MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics and Preliminary Imaging of <sup>68</sup>Ga-NeoBOMB1, a Gastrin-releasing Peptide Receptor Antagonist, in GIST Patients.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.238808
    By:
    • Gruber, Leonhard;
    • Jimenez, Luis David;
    • Decristoforo, Clemens;
    • Uprimny, Christian;
    • Glatting, Gerhard;
    • Hohenberger, Peter;
    • Schoenberg, Stefan O.;
    • Reindl, Wolfgang;
    • Orlandi, Francesca;
    • Mariani, Maurizio;
    • Jaschke, Werner;
    • Virgolini, Irene
    Publication type:
    Article
    7
    8

    MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics and Preliminary Imaging of <sup>68</sup>Ga-NeoBOMB1, a Gastrin-releasing Peptide Receptor Antagonist, in GIST Patients.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.239095
    By:
    • Gruber, Leonhard;
    • Jimenez, Luis David;
    • Decristoforo, Clemens;
    • Uprimny, Christian;
    • Glatting, Gerhard;
    • Hohenberger, Peter;
    • Schoenberg, Stefan O.;
    • Reindl, Wolfgang;
    • Orlandi, Francesca;
    • Mariani, Maurizio;
    • Jaschke, Werner;
    • Virgolini, Irene
    Publication type:
    Article
    9
    10

    MITIGATE‐NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics and Preliminary Imaging of <sup>68</sup>Ga‐NeoBOMB1, a Gastrin‐releasing Peptide Receptor Antagonist, in GIST Patients.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.238808
    By:
    • Gruber, Leonhard;
    • Jimenez, Luis David;
    • Decristoforo, Clemens;
    • Uprimny, Christian;
    • Glatting, Gerhard;
    • Hohenberger, Peter;
    • Schoenberg, Stefan O.;
    • Reindl, Wolfgang;
    • Orlandi, Francesca;
    • Mariani, Maurizio;
    • Jaschke, Werner;
    • Virgolini, Irene
    Publication type:
    Article
    11
    12

    MITIGATE‐NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics and Preliminary Imaging of 68Ga‐NeoBOMB1, a Gastrin‐releasing Peptide Receptor Antagonist, in GIST Patients.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.238808
    By:
    • Gruber, Leonhard;
    • Jimenez, Luis David;
    • Decristoforo, Clemens;
    • Uprimny, Christian;
    • Glatting, Gerhard;
    • Hohenberger, Peter;
    • Schoenberg, Stefan O.;
    • Reindl, Wolfgang;
    • Orlandi, Francesca;
    • Mariani, Maurizio;
    • Jaschke, Werner;
    • Virgolini, Irene
    Publication type:
    Article
    13

    MITIGATE‐NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics and Preliminary Imaging of <sup>68</sup>Ga‐NeoBOMB1, a Gastrin‐releasing Peptide Receptor Antagonist, in GIST Patients.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.238808
    By:
    • Gruber, Leonhard;
    • Jimenez, Luis David;
    • Decristoforo, Clemens;
    • Uprimny, Christian;
    • Glatting, Gerhard;
    • Hohenberger, Peter;
    • Schoenberg, Stefan O.;
    • Wolfgang Reindl;
    • Orlandi, Francesca;
    • Mariani, Maurizio;
    • Jaschke, Werner;
    • Virgolini, Irene
    Publication type:
    Article
    14

    MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics and Preliminary Imaging of <sup>68</sup>Ga-NeoBOMB1, a Gastrin-releasing Peptide Receptor Antagonist, in GIST Patients.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.238808
    By:
    • Gruber, Leonhard;
    • Jimenez, Luis David;
    • Decristoforo, Clemens;
    • Uprimny, Christian;
    • Glatting, Gerhard;
    • Hohenberger, Peter;
    • Schoenberg, Stefan O.;
    • Reindl, Wolfgang;
    • Orlandi, Francesca;
    • Mariani, Maurizio;
    • Jaschke, Werner;
    • Virgolini, Irene
    Publication type:
    Article
    15

    MITIGATE‐NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics and Preliminary Imaging of <sup>68</sup>Ga‐NeoBOMB1, a Gastrin‐releasing Peptide Receptor Antagonist, in GIST Patients.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.238808
    By:
    • Gruber, Leonhard;
    • Jimenez, Luis David;
    • Decristoforo, Clemens;
    • Uprimny, Christian;
    • Glatting, Gerhard;
    • Hohenberger, Peter;
    • Schoenberg, Stefan O.;
    • Reindl, Wolfgang;
    • Orlandi, Francesca;
    • Mariani, Maurizio;
    • Jaschke, Werner;
    • Virgolini, Irene
    Publication type:
    Article
    16

    MITIGATE&-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics and Preliminary Imaging of <sup>68</sup>Ga-NeoBOMB1, a Gastrin-releasing Peptide Receptor Antagonist, in GIST Patients.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.238808
    By:
    • Gruber, Leonhard;
    • Jimenez, Luis David;
    • Decristoforo, Clemens;
    • Uprimny, Christian;
    • Glatting, Gerhard;
    • Hohenberger, Peter;
    • Schoenberg, Stefan O.;
    • Reindl, Wolfgang;
    • Orlandi, Francesca;
    • Mariani, Maurizio;
    • Jaschke, Werner;
    • Virgolini, Irene
    Publication type:
    Article
    17

    Modeling and Predicting Tumor Response in Radioligand Therapy.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 1, p. 65, doi. 10.2967/jnumed.118.210377
    By:
    • Kletting, Peter;
    • Thieme, Anne;
    • Eberhardt, Nina;
    • Rinscheid, Andreas;
    • D’Alessandria, Calogero;
    • Allmann, Jakob;
    • Wester, Hans-Jürgen;
    • Tauber, Robert;
    • Beer, Ambros J.;
    • Glatting, Gerhard;
    • Eiber, Matthias
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Imaging Prostate Cancer with <sup>11</sup>C-Choline PET/CT.

    Published in:
    Journal of Nuclear Medicine, 2006, v. 47, n. 8, p. 1249
    By:
    • Reske, Sven N.;
    • Blumstein, Norbert M.;
    • Neumaier, Bernd;
    • Gottfried, Hans-Werner;
    • Finsterbusch, Frank;
    • Kocot, Darius;
    • Möller, Peter;
    • Glatting, Gerhard;
    • Perner, Sven
    Publication type:
    Article
    27

    Bone Marrow Transplantation Nephropathy after an Intensified Conditioning Regimen with Radioimmunotherapy and Allogeneic Stem Cell Transplantation.

    Published in:
    Journal of Nuclear Medicine, 2006, v. 47, n. 2, p. 278
    By:
    • Zenz, Thorsten;
    • Schlenk, Richard F.;
    • Glatting, Gerhard;
    • Neumaier, Bernd;
    • Blumstein, Norbert;
    • Buchmann, Inga;
    • von Harsdorf, Stephanie;
    • Ringhoffer, Mark;
    • Wiesneth, Markus;
    • Keller, Frieder;
    • Kotzerke, Jörg;
    • Röttinger, Erwin;
    • Stilgenbauer, Stephan;
    • Döhner, Hartmut;
    • Reske, Sven N.;
    • Bunjes, Donald
    Publication type:
    Article
    28
    29
    30
    31
    32

    Exploratory Tau PET/CT with [11C]PBB3 in Patients with Suspected Alzheimer's Disease and Frontotemporal Lobar Degeneration: A Pilot Study on Correlation with PET Imaging and Cerebrospinal Fluid Biomarkers.

    Published in:
    Biomedicines, 2024, v. 13, n. 7, p. 1460, doi. 10.3390/biomedicines12071460
    By:
    • Strobel, Joachim;
    • Yousefzadeh-Nowshahr, Elham;
    • Deininger, Katharina;
    • Bohn, Karl Peter;
    • von Arnim, Christine A. F.;
    • Otto, Markus;
    • Solbach, Christoph;
    • Anderl-Straub, Sarah;
    • Polivka, Dörte;
    • Fissler, Patrick;
    • Glatting, Gerhard;
    • Riepe, Matthias W.;
    • Higuchi, Makoto;
    • Beer, Ambros J.;
    • Ludolph, Albert;
    • Winter, Gordon
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    <sup>188</sup>Re or <sup>90</sup>Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I–II study.

    Published in:
    British Journal of Haematology, 2005, v. 130, n. 4, p. 604, doi. 10.1111/j.1365-2141.2005.05663.x
    By:
    • Ringhoffer, Mark;
    • Blumstein, Norbert;
    • Neumaier, Bernd;
    • Glatting, Gerhard;
    • von Harsdorf, Stephanie;
    • Buchmann, Inga;
    • Wiesneth, Markus;
    • Kotzerke, Jörg;
    • Zenz, Thorsten;
    • Buck, Andreas K.;
    • Schauwecker, Peter;
    • Stilgenbauer, Stephan;
    • Döhner, Hartmut;
    • Reske, Sven N.;
    • Bunjes, Donald
    Publication type:
    Article
    45

    Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 9, p. 2595, doi. 10.1007/s00259-023-06215-2
    By:
    • Gabiña, Pablo Mínguez;
    • Gleisner, Katarina Sjögreen;
    • Cremonesi, Marta;
    • Stokke, Caroline;
    • Flux, Glenn;
    • Cicone, Francesco;
    • Konijnenberg, Mark;
    • Aldridge, Matt;
    • Sandstrom, Mattias;
    • Chiesa, Carlo;
    • Paphiti, Maria;
    • Hippeläinen, Eero;
    • Uribe, Carlos;
    • Solny, Pavel;
    • Gnesin, Silvano;
    • Bernhardt, Peter;
    • Chouin, Nicolas;
    • Costa, Pedro Fragoso;
    • Glatting, Gerhard;
    • Verburg, Frederik
    Publication type:
    Article
    46
    47

    EANM position paper on the role of radiobiology in nuclear medicine.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 11, p. 3365, doi. 10.1007/s00259-021-05345-9
    By:
    • Aerts, An;
    • Eberlein, Uta;
    • Holm, Sören;
    • Hustinx, Roland;
    • Konijnenberg, Mark;
    • Strigari, Lidia;
    • van Leeuwen, Fijs W.B.;
    • Glatting, Gerhard;
    • Lassmann, Michael
    Publication type:
    Article
    48
    49
    50

    Performance of integrated FDG-PET/CT for differentiating benign and malignant lung lesions--results from a large prospective clinical trial.

    Published in:
    2008
    By:
    • Sandra Pauls;
    • Andreas Buck;
    • Gisela Halter;
    • Felix Mottaghy;
    • Rainer Muche;
    • Christina Bluemel;
    • Susanne Gerstner;
    • Stefan Krüger;
    • Gerhard Glatting;
    • Ludger Sunder-Plassmann;
    • Peter Möller;
    • Hans-Jürgen Brambs;
    • Sven Reske;
    • Pauls, Sandra;
    • Buck, Andreas K;
    • Halter, Gisela;
    • Mottaghy, Felix M;
    • Muche, Rainer;
    • Bluemel, Christina;
    • Gerstner, Susanne
    Publication type:
    journal article